Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Telix Pharmaceuticals LtdTLX · Entity 4101 | Director · MD & Group CEO | April 28, 2026 | May 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Telix Pharmaceuticals Ltd
Report date April 28, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectElk River Holdings Pty Ltd | 20,742,935 |
Last balance in matching sequence
After 2026-04-29 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-04-28 · Purchase · Acquired 34,500 · Balance 20,709,500 F1: The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. F2: The purchase prices are reported in Australian Dollars. F3: Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd. Row 2 · 2026-04-29 · Purchase · Acquired 33,435 · Balance 20,742,935 F2: The purchase prices are reported in Australian Dollars. F4: The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4. F3: Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2: The purchase prices are reported in Australian Dollars.
F3: Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd.
F4: The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 29, 2026 Filed May 7, 2026 01:32 UTC | Telix Pharmaceuticals Ltd TLX · Entity 4101 | PurchaseOrdinary Shares | 33,435 | $14.87 | $497,178.45 |
DisclosureSEC source: 0001628280-26-031608 · wk-form4_1778117523.xml · nonDerivative · entry 2 Behrenbruch Christian · CIK 0002037713 · Director · MD & Group CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Elk River Holdings Pty Ltd Disclosed balance after: 20,742,935 F2 · price: The purchase prices are reported in Australian Dollars. F4 · price: The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.54 - $14.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4. F3 · ownership.nature: Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd. Read SEC document |
| April 28, 2026 Filed May 7, 2026 01:32 UTC | Telix Pharmaceuticals Ltd TLX · Entity 4101 | PurchaseOrdinary Shares | 34,500 | $14.48 | $499,560.00 |
DisclosureSEC source: 0001628280-26-031608 · wk-form4_1778117523.xml · nonDerivative · entry 1 Behrenbruch Christian · CIK 0002037713 · Director · MD & Group CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Elk River Holdings Pty Ltd Disclosed balance after: 20,709,500 F1 · price: The price reported in Column 4 is an average price. The shares were purchased in multiple transactions at prices ranging from $14.42 - $14.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (SEC), upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. F2 · price: The purchase prices are reported in Australian Dollars. F3 · ownership.nature: Dr. Behrenbruch is the sole director and shareholder of Elk River Holdings Pty Ltd. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.